TO ESTABLISH A GLOBALLY NATIONAL ENTERPRISE
WITH CHINESE CHARACTERISTICS.
Zhanlong Dong
Chairman
-
- 160 +
- Patents
-
- 100,000 ㎡+
- Plant
-
- 3
- R&D Centers
-
-
2022-2026
MRC diversified business
-
・In 2022,MRC upgraded it’s business with multi-platform, multi-brand and diversified strategic blueprint
・In 2023, set up subsidiaries: CRETIA, MRC (Huizhou Company), DROPHIL, COLINWI and etc.,
・In 2024, business expansion in Personal Care & Hygiene Products with brand YESHE and JUMPTO
-
-
-
2019 - 2021
MRC launched the globalization strategy
-
・To fight against the COVID-19 pandemic, formed a strategic cooperation with the Huoyan laboratory
・Timely supplied anti-epidemic materials to the WHO and governments of various countries, made a great contribution to fight against COVID-19 globally
・MANTACC has been covered over 120 countries and regions worldwide and became a top brand all over the world
-
-
-
2012 - 2018
MRC expanded to the medical field
-
・In 2012, the first one to obtain the Class Ⅱ Medical Device Registration Certificate, Medical Device Production License in China
・In 2016, launched our own brand MANTACC to the international market
・In 2017, recognized as a National High-Tech Enterprise
・In 2018, got FDA, CE approved
-
-
-
2003 - 2011
In the early stage of MRC development
-
・As a leader of industrial wiping and cleaning, MRC focused on contamination control in cleanrooms, semiconductors, aerospace, microelectronics, and financial office equipment in the beginning
・In 2009, MRC has been involved in healthcare, bio-pharmaceuticals, medical devices, food safety, focused on human health
-